JMS

Hiroshima, Japan Founded: 1965 • Age: 61 yrs Listed
Dietary supplements for gut health are manufactured and distributed.

About JMS

JMS is a publicly listed company based in Hiroshima (Japan) founded in 1965. Dietary supplements for gut health are manufactured and distributed. The company has 5,470 employees. Its chief executive, as recorded, is Hiroaki Okukubo. Its website jms.cc draws about 51 thousand monthly visits. JMS offers products and services including Medical Devices and Sustainability Services. Its focus areas include Traditional Medical Devices. Its legal entity is JMS Co., Ltd.

Company details

Founded in 1965 in Hiroshima, Japan, dietary supplements centered on gut health are produced and distributed by the company. Operations encompass the creation of products such as digestive enzymes, probiotics, and botanical nutrients aimed at supporting digestive function and related wellness aspects. Educational materials on gut health are also shared through online blogs and channels. The focus remains on addressing digestion-specific concerns within the health sector.

  • Headquarters Hiroshima, Japan
  • Employees 5,470
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website jms.cc
  • Social LinkedIn
  • Legal Name Jms Co., Ltd.
Key Metrics
  • Annual Revenue
    $412.8 M (USD)
    -5.6
    as on Mar 31, 2026
  • Net Profit
    -$4.92 M (USD)
    -980.9
    as on Mar 31, 2026
  • EBITDA
    $26.46 M (USD)
    -11.47
    as on Mar 31, 2026
  • Employee Count
    5,470

Products & Services of JMS

JMS offers a comprehensive portfolio of products and services, including Medical Devices and Sustainability Services.

Medical Devices
Healthcare Products

Medical devices are produced for applications in healthcare, including support for dialysis and regenerative medicine, to address patient needs.

Sustainability Services
Corporate Services

Sustainability services are offered to manage environmental and social responsibilities, focusing on initiatives that align with corporate goals.

People of JMS

1 people are tracked at JMS (1 in leadership); the tracked headcount is 5,470.

NameRoleGroup
Hiroaki Okukubo
President & CEOLeadership
Premium access

Complete people profiles for JMS

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of JMS

JMS is a publicly listed company on the TSE with ticker symbol 7702 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date13 Mar 1989
  • Listed onTSE: 7702
  • Listed entityJMS Co., Ltd.
  • Exchange sectorHealth technology
  • ISINJP3386050003
  • Share price442.00 JPY (-0.67% on the day) · 2026-10-14
  • Market capitalisation10,872,259,169.00 JPY
  • Price to earnings68.0
  • EPS (diluted, trailing year)-28.66 JPY
  • Dividend yield3.82%
  • Volume (last session)26,500

Financials of JMS

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
202565.84B JPY-784.0M JPY4.22B JPY
202469.75B JPY89.0M JPY4.76B JPY
202365.29B JPY-36.0M JPY3.45B JPY
202263.74B JPY280.0M JPY4.32B JPY
202158.17B JPY825.0M JPY4.34B JPY
Premium access

Detailed financial statements for JMS

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of JMS

The website of JMS (jms.cc) receives about 51.3K visits a month.

  • Monthly visits
    51.3K

    ▲ 4.1% vs previous month

Similar websites

Websites whose visitors overlap most with JMS. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
hope-denshi.co.jp
hope-denshi.co.jp
100%
#8,531,116–
cardinalhealth-info.jp
cardinalhealth-info.jp
84%
#687,910–
gadeliusmedical.com
gadeliusmedical.com
82%
#2,967,522–
bbraun.jp
bbraun.jp
81%
#1,170,910–
www3.gehealthcare.co.jp
www3.gehealthcare.co.jp
80%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for JMS

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Jms

TABLE-JMS -Q1 group results
Reuters β€’ 3 months ago
TABLE-JMS -2025/26 group results
Reuters β€’ 6 months ago
TABLE-JMS - 9-MTH group results
Reuters β€’ 9 months ago
TABLE-JMS - 6-MTH group results
Reuters β€’ 1 year ago
TABLE-JMS -Q1 group results
Reuters β€’ 2 years ago
Premium access

Complete news archive for JMS

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about JMS

JMS was founded in 1965.

JMS is headquartered in Hiroshima, Japan.

Hiroaki Okukubo is the CEO of JMS, as recorded in our data.

JMS has 5,470 employees.

Annual revenue of JMS is $412.8M as on Mar 31, 2026.

Founded in 1965 in Hiroshima, Japan, dietary supplements centered on gut health are produced and distributed by the company. Operations encompass the creation of products such as digestive enzymes, probiotics, and botanical nutrients aimed at supporting digestive function and related wellness aspects. Educational materials on gut health are also shared through online blogs and channels. The focus remains on addressing digestion-specific concerns within the health sector.

JMS offers Medical Devices and Sustainability Services.

Yes, JMS is publicly traded on TSE under the ticker symbol 7702.

JMS operates through Jms Co., Ltd..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available